Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

NCT06456346 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Thrombocythemia

Interventions

DRUG: Bomedemstat
DRUG: Hydroxyurea
DRUG: Bomedemstat placebo
DRUG: Hydroxyurea placebo

Sponsor

Merck Sharp & Dohme LLC